All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
  TRANSLATE

The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

REVEAL study: What have been the most common causes of mortality for patients with PV?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to Brady L. Stein, Northwestern University, Evanston, US, about the most common causes of mortality for patients with polycythemia vera (PV).

REVEAL study: What have been the most common causes of mortality for patients with PV?

Stein gives an overview of the key findings from the REVEAL study: patients who died during the study were older and categorized as high-risk (aged ≥ 60 years and/or history of thrombosis) at diagnosis compared with patients who were alive. The most common causes of death included: vascular complications, hematological transformations, and respiratory failure.